Psychiatry & Neurology, Neuromuscular Medicine · Seattle, WA
NPI
1629430137
Since 2016
Specialty
Psychiatry & Neurology, Neuromuscular Medicine
Code 2084N0008X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
550 17th Ave Ste 400
Seattle, WA, 98122
Phone (206) 320-3494
Groups this clinician bills Medicare through
Medicare paid, 2024
$83K
3,277 services
Medicare patients, 2024
246
Average age 74
Drug cost, 2024
$3.7M
1,347 prescriptions
Company payments, 2025
$203
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David N Ivanick was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 155 times for 109 patients. In total David N Ivanick billed 3,277 services in 25 codes, and Medicare paid $83K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-17.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 155 | 109 | $13.75 | $2,131 |
| 99215 Office E&M - Established | Office | 125 | 81 | $147.40 | $18K |
| 99214 Office E&M - Established | Office | 107 | 84 | $103.42 | $11K |
| 95886 Electrical Nerve Conductivity | Office | 96 | 55 | $86.77 | $8,330 |
| 99213 Office E&M - Established | Office | 72 | 59 | $71.25 | $5,130 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 54 | 31 | $26.68 | $1,441 |
| 99205 Office E&M - New | Office | 53 | 53 | $174.27 | $9,236 |
| 95909 Electrical Nerve Conductivity | Office | 15 | 15 | $109.07 | $1,636 |
| 95911 Electrical Nerve Conductivity | Office | 14 | 14 | $181.68 | $2,543 |
| 99204 Office E&M - New | Office | 13 | 13 | $139.72 | $1,816 |
| 95912 Electrical Nerve Conductivity | Office | 13 | 13 | $218.97 | $2,847 |
| 95910 Electrical Nerve Conductivity | Office | 11 | 11 | $143.87 | $1,583 |
By year: 2022 $65K for 2,767 services; 2023 $70K for 1,020 services; 2024 $83K for 3,277 services.
Medicare prescription drug claims, 2024
In 2024, the drug David N Ivanick prescribed most often to Medicare patients was Radicava Ors (Edaravone), with 155 prescriptions and refills. In total David N Ivanick wrote 1,347 Medicare prescriptions that cost $3.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Radicava Ors Edaravone | 155 | 156 | 18 | $2.2M |
| Gabapentin Generic | 114 | 186 | 31 | $1,802 |
| Riluzole Generic | 103 | 143 | 22 | $34K |
| Mycophenolate Mofetil Generic | 86 | 157 | 18 | $9,928 |
| Pyridostigmine Bromide Generic | 79 | 115 | 15 | $3,896 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 56 | 101 | 13 | $1,087 |
| Duloxetine Hcl Generic | 48 | 90 | Under 11 | $562 |
| Pregabalin Generic | 48 | 76 | Under 11 | $1,481 |
| Levetiracetam Generic | 41 | 62 | Under 11 | $649 |
| Baclofen Generic | 39 | 39 | Under 11 | $493 |
| Memantine Hcl Generic | 38 | 74 | Under 11 | $898 |
| Prednisone Generic | 35 | 86 | 11 | $487 |
| Nuedexta Dextromethorphan Hbr/Quinidine | 33 | 33 | Under 11 | $55K |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 30 | 30 | Under 11 | $208K |
| Privigen Immun Glob G(Igg)/Pro/Iga 0-50 | 30 | 30 | Under 11 | $445K |
Brand drugs: 369 claims; generic drugs: 978 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David N Ivanick $203 ($203 in general payments such as food, travel and fees) from 5 companies. The largest payer was Grifols USA, LLC with $66.47.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.